ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Clinical Cardiac Electrophysiology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,622Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 13

$688K Total Retail Price of All Prescriptions

Rank: 2 out of 13

976 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
18% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 11,946 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $68 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
METOPROLOL SUCCINATE 1,027 915 1 1
FUROSEMIDE 921 761 2 3
AMLODIPINE BESYLATE 707 634 3 6
CARVEDILOL 649 559 4 5
METOPROLOL TARTRATE 573 507 5 7
SIMVASTATIN 543 480 6 11
WARFARIN SODIUM 454 416 7 2
LISINOPRIL 451 383 8 4
ATORVASTATIN CALCIUM 362 324 9 14
HYDROCHLOROTHIAZIDE 301 241 10 16
BENAZEPRIL HCL 298 261 11 30
POTASSIUM CHLORIDE 289 253 12 21
CLOPIDOGREL 286 251 13 15
PROPAFENONE HCL 255 247 14 23
AMLODIPINE BESYLATE-BENAZEPRIL 239 184 15 35
ATENOLOL 231 222 16 9
LOSARTAN POTASSIUM 212 175 17 28
PRADAXA 211 207 18 10
DIGOXIN 205 163 19 8
PLAVIX 205 189 19 20
ISOSORBIDE MONONITRATE ER 192 162 21 34
AMIODARONE HCL 183 153 22 12
CRESTOR 181 148 23 24
DIOVAN 180 169 24 27
KLOR-CON M20 165 141 25 41
SOTALOL 161 160 26 18
BYSTOLIC 143 135 27 38
XARELTO 139 139 28 29
QUINAPRIL HCL 139 130 28 42
TIKOSYN 131 118 30 13
VYTORIN 125 107 31 35
NITROSTAT 120 102 32 45
EXFORGE 113 110 33 53
PACERONE 105 94 34 40
BUMETANIDE 103 73 35 25
PRAVASTATIN SODIUM 101 101 36 22
DILTIAZEM 24HR ER 83 83 37 31
SPIRONOLACTONE 79 74 38 17
LOSARTAN-HYDROCHLOROTHIAZIDE 75 75 39 56
JANTOVEN 73 73 40 33
FENOFIBRATE 72 58 41 59
RANEXA 70 44 42 47
RAMIPRIL 67 55 43 32
CLONIDINE HCL 64 51 44 64
DILTIAZEM 24HR CD 61 61 45 51
KLOR-CON 10 60 49 46 67
LIPITOR 60 60 46 48
EFFIENT 59 57 48 68
LISINOPRIL-HYDROCHLOROTHIAZIDE 55 55 49 70
MULTAQ 53 53 50 26
PANTOPRAZOLE SODIUM 51 46 51 73
LOVASTATIN 51 51 51 52
TRANDOLAPRIL 50 40 53 74
HYDRALAZINE HCL 50 45 53 43
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 1, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.